Aurobindo Pharma gains on concluding acquisition of Natrol

08 Dec 2014 Evaluate

Aurobindo Pharma is currently trading at Rs. 1129.65, up by 6.05 points or 0.54% from its previous closing of Rs. 1123.60 on the BSE.

The scrip opened at Rs. 1134.15 and has touched a high and low of Rs. 1136.50 and Rs. 1128.20 respectively. So far 3,405 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1158.90 on 02-Dec-2014 and a 52 week low of Rs. 290.65 on 06-Dec-2013.

Last one week high and low of the scrip stood at Rs. 1158.90 and Rs. 1091.75 respectively. The current market cap of the company is Rs. 32,986.00 crore.

The promoters holding in the company stood at 54.10% while Institutions and Non-Institutions held 35.67% and 10.22% respectively.

Aurobindo Pharma has completed the acquisition of assets of nutritional supplement maker, Natrol Inc. and other affiliate entities (Natrol) through its wholly owned subsidiary Aurobindo Pharma USA Inc. (APUSA). APUSA emerged as the highest and best bidder to acquire assets of Natrol under the auction process by the United States Bankruptcy Court for the District of Delaware was previously announced on November 12, 2014.

APUSA acquired the manufacturing assets, personnel, commercial infrastructure including the well established nutraceuticals brands in USA of Natrol along with an agreement to take on certain liabilities, with a bid of $132.5 million. The assets have been acquired under a wholly owned subsidiary ‘Nature Acquisition LLC’ and since changed to Natrol LLC. The final terms of acquisition are the same as originally envisaged during announcement made earlier.

APUSA expects the profitability to improve by combining the strength of both enterprises in creating a fully integrated nutraceuticals platform in the USA and other international markets.

Aurobindo Pharma manufactures generic pharmaceuticals and active pharmaceutical ingredients. The company’s robust product portfolio is spread over 6 major therapeutic/product areas encompassing Antibiotics, Anti-Retrovirals, CVS, CNS, Gastroenterologicals, and Anti-Allergics, supported by an outstanding R&D set-up.

Aurobindo Pharma Share Price

1217.45 -6.20 (-0.51%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×